Indero emerges as rebranded Innovaderm, strengthening dermatology and rheumatology clinical research
Innovaderm Research has officially rebranded as Indero, reflecting its commitment to dermatology and rheumatology clinical trials. The transformation underscores the company’s longstanding expertise in immune-mediated ... Read More
Lightview Capital sells Array to WCG: A strategic move in clinical research solutions
Lightview Capital, a notable lower middle market private equity firm, has successfully executed the sale of Array, a prominent content engagement partner for life sciences ... Read More
Roche reports setback in lung cancer study with tiragolumab and tecentriq combination
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced disappointing results from the phase II/III SKYSCRAPER-06 study, aimed at evaluating the efficacy of tiragolumab plus Tecentriq ... Read More
Xeris Pharmaceuticals begins Phase 2 trial for glucagon in Type 1 diabetes patients
Xeris Pharmaceuticals, a specialty pharmaceutical company based in Chicago, has announced the commencement of dosing in its phase 2 clinical trial. The trial aims to ... Read More
PvP Biologics launches Phase 1 trials for celiac disease candidate Kuma062
PvP Biologics, a US-based pharmaceutical company, has recently begun two phase 1 clinical trials to assess the safety, tolerability, and pharmacodynamics of Kuma062, a promising ... Read More
Tolero Pharmaceuticals and AbbVie collaborate to advance AML treatment
Tolero Pharmaceuticals has entered into a clinical research collaboration with AbbVie to explore the potential of combining their respective drugs, alvocidib and venetoclax, for the ... Read More